ResearcherSt John of God Subiaco HospitalNo recent work listed

Adarsh Das

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0001-6289-4319; OpenAlex author ID A5022112281. Sources: OpenAlex.

Their work

Papers: 2
Trials: 0
Grants: 0
Labs led: 0
Collaborators: 3

Papers, trials and grants by year

2019: 1 paper · 2020: none · 2021: none · 2022: none · 2023: 1 paper

Papers 2

Overall survival and treatment modalities in pancreatic adenocarcinoma: a retrospective analysis of a single centre in Western Australia. Co-author DOI 10.21037/jgo-23-488 ↗
Gemcitabine-induced haemolytic uraemic syndrome in pancreatic adenocarcinoma. Co-author DOI 10.1136/bcr-2018-228363 ↗

Closest collaborators

The 3 strongest of 3 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

Andrew Peter Dean · 2 shared papers, 2019–2023 · strength 0.32
- Paper Overall survival and treatment modalities in pancreatic adenocarcinoma: a retrospective analysis of a single centre in … DOI 10.21037/jgo-23-488 ↗
- Paper Gemcitabine-induced haemolytic uraemic syndrome in pancreatic adenocarcinoma. DOI 10.1136/bcr-2018-228363 ↗
Alice Talbot · 1 shared paper, 2023 · strength 0.16
- Paper Overall survival and treatment modalities in pancreatic adenocarcinoma: a retrospective analysis of a single centre in … DOI 10.21037/jgo-23-488 ↗
Timothy Dudley Clay · 1 shared paper, 2019 · strength 0.16
- Paper Gemcitabine-induced haemolytic uraemic syndrome in pancreatic adenocarcinoma. DOI 10.1136/bcr-2018-228363 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.